Skip to main content
logo
Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
3.880
+0.340 (9.60%)
At close: Mar 9, 2026, 4:00 PM EDT
3.820
-0.060 (-1.55%)
After-hours: Mar 9, 2026, 7:59 PM EDT

Altimmune Market Cap

Altimmune has a market cap or net worth of $504.67 million as of March 9, 2026. Its market cap has increased by 7.01% in one year.

Market Cap
504.67M
Enterprise Value
266.90M
1-Year Change
7.01%
Ranking
#3097
Category
Small-Cap
Stock Price
$3.88

Market Cap Chart

Since October 6, 2005, Altimmune's market cap has increased from $81.50M to $504.67M, an increase of 519.23%. That is a compound annual growth rate of 9.34%.

History

DateMarket Cap% Change
Mar 6, 2026460.40M22.32%
Dec 31, 2025376.40M-26.60%
Dec 31, 2024512.80M-15.16%
Dec 29, 2023604.40M-25.26%
Dec 30, 2022808.70M122.17%
Dec 31, 2021364.00M-2.41%
Dec 31, 2020373.00M1,186.21%
Dec 31, 201929.00M61.11%
Dec 31, 201818.00M-42.12%
Dec 29, 201731.10M-85.66%
Dec 30, 2016216.90M77.06%
Dec 31, 2015122.50M6.80%
Dec 31, 2014114.70M17.88%
Dec 31, 201397.30M79.52%
Dec 31, 201254.20M-11.58%
Dec 30, 201161.30M-64.57%
Dec 31, 2010173.00M210.59%
Dec 31, 200955.70M-6.39%
Dec 31, 200859.50M-31.77%
Dec 31, 200787.20M1.04%
Dec 29, 200686.30M4.10%
Dec 30, 200582.90M1.72%
Oct 6, 200581.50M-
View and export this data all the way back to 2005. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

CompanyMarket Cap
Century Therapeutics528.16M
Prothena Corporation528.10M
Relmada Therapeutics525.80M
ADC Therapeutics524.00M
CorMedix518.57M
Rigel Pharmaceuticals518.54M
Zevra Therapeutics513.43M
Vanda Pharmaceuticals513.06M
Market Cap Rankings